Organogenesis Holdings Inc. ORGO Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Organogenesis Holdings Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Organogenesis Holdings Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Organogenesis Holdings Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Organogenesis Holdings Inc.'s operating cash flow?
- Organogenesis Holdings Inc. (ORGO) reported operating cash flow of $21.13M in Q1 2026.
- How has Organogenesis Holdings Inc.'s operating cash flow changed year-over-year?
- Organogenesis Holdings Inc.'s operating cash flow increased by 206.0% year-over-year, from -$19.94M to $21.13M.
- What is the long-term trend for Organogenesis Holdings Inc.'s operating cash flow?
- Over 3 years (2021 to 2024), Organogenesis Holdings Inc.'s operating cash flow has grown at a -38.8% compound annual growth rate (CAGR), from $61.98M to $14.21M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.